American Society of Hematology

Action Alerts

From time to time ASH will call on its members to reach out to Congress and state legislatures on issues of importance to hematologists and their patients. Below is a list of current issues of importance.

Federal Campaigns

Thank Your Members of Congress for Their Commitment to NIH Funding in FY 2020
Over the past several months, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of increased funding for the National Institutes of Health (NIH). Because of your efforts and the work of medical research advocates across the country, Congress passed final fiscal year (FY) 2020 appropriations legislation in late December that included a $2.6 billion dollar increase to the NIH for a total funding level of $41.7 billion. President Trump signed the funding bill into law on December 19.

Urge Your Senators and Representative to Support the Cancer Drug Coverage Parity Act
Legislation has been reintroduced in the U.S. House of Representatives and U.S. Senate that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. The Cancer Drug Coverage Parity Act would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port administered, or injected anticancer medications.

State-Level Campaigns

Write Your New Jersey Legislators to Support Patients' Access to Care
Vital access to care legislation has passed both chambers of the New Jersey Legislature and has been sent to the Governor’s desk. This legislation, A.2431, would ensure patients have access to the life-saving medication prescribed to them by their physicians and will place maximums on the out-of-pocket costs that patients can be required to pay for each prescription medication, regardless of the disease.

back to top